EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Avidity Biosciences, Inc. (RNA) had EBIT Margin of -4448.71% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$3.85M |
|
$-157.31M |
|
-- |
|
$3.85M |
|
$174.99M |
|
$-171.14M |
|
$13.83M |
|
$-157.31M |
|
$-157.31M |
|
$-157.31M |
|
$-157.31M |
|
$-157.31M |
|
$-157.31M |
|
$-171.14M |
|
$-173.80M |
|
129.62M |
|
129.62M |
|
$-1.21 |
|
$-1.21 |
|
| Balance Sheet Financials | |
$1.25B |
|
$20.54M |
|
$118.37M |
|
$1.37B |
|
$135.06M |
|
-- |
|
$41.20M |
|
$176.26M |
|
$1.19B |
|
$1.19B |
|
$1.19B |
|
120.78M |
|
| Cash Flow Statement Financials | |
$-324.50M |
|
$342.67M |
|
$5.71M |
|
$222.66M |
|
$246.71M |
|
$24.04M |
|
$35.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4448.71% |
|
|
EBIT Margin |
-4448.71% |
-- |
|
-4089.29% |
|
-4089.29% |
|
$-331.59M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-13.19% |
|
-13.19% |
|
-11.49% |
|
-13.19% |
|
$9.87 |
|
$-2.56 |
|
$-2.50 |
|